Q2 2025 Holdings
Filed 2025-08-14 | 200 holdings | $2.0B | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Galapagos NV(GLPG) | SPON ADR | 36315X101 | $111.7M | 3,990,111 | 5.6% |
| Tarsus Pharmaceuticals Inc(TARS) | COM | 87650L103 | $99.4M | 2,454,797 | 5.0% |
| Aurinia Pharmaceuticals Inc(AUPH) | COM | 05156V102 | $84.9M | 10,029,500 | 4.3% |
| Immunocore Hldgs PLC(IMCR) | ADS | 45258D105 | $66.1M | 2,105,608 | 3.3% |
| Kiniksa Pharmaceuticals Intl(KNSA) | ORD SHS CL A | G52694109 | $64.4M | 2,328,609 | 3.3% |
| Mirum Pharmaceuticals Inc(MIRM) | COM | 604749101 | $62.9M | 1,236,027 | 3.2% |
| Kalvista Pharmaceuticals Inc(KALV) | COM | 483497103 | $55.9M | 4,941,798 | 2.8% |
| PTC Therapeutics Inc(PTCT) | COM | 69366J200 | $53.7M | 1,100,000 | 2.7% |
| Spyre Therapeutics Inc(SYRE) | COM NEW | 00773J202 | $47.9M | 3,200,000 | 2.4% |
| Evolus Inc(EOLS) | COM | 30052C107 | $46.0M | 4,997,399 | 2.3% |
| Viridian Therapeutics Inc(VRDN) | COM | 92790C104 | $39.7M | 2,842,925 | 2.0% |
| Iteos Therapeutics Inc(5E7) | COM | 46565G104 | $38.2M | 3,826,692 | 1.9% |
| Compass Therapeutics Inc(CMPX) | COM | 20454B104 | $35.1M | 13,496,208 | 1.8% |
| Acadia Pharmaceuticals Inc(ACAD) | COM | 004225108 | $32.4M | 1,500,000 | 1.6% |
| Vera Therapeutics Inc CL A(VERA) | CL A | 92337R101 | $31.8M | 1,350,000 | 1.6% |
| Merus N V | COM | N5749R100 | $31.6M | 600,000 | 1.6% |
| Replimune Group Inc(REPL) | COM | 76029N106 | $29.7M | 3,200,000 | 1.5% |
| Anaptysbio Inc(ANAB) | COM | 032724106 | $29.5M | 1,330,879 | 1.5% |
| Legend Biotech Corp(LEGN) | SPONSORED ADS | 52490G102 | $29.5M | 830,000 | 1.5% |
| Biontech SE(BNTX) | SPONSORED ADS | 09075V102 | $28.7M | 270,000 | 1.5% |
| Relay Therapeutics Inc(RLAY) | COM | 75943R102 | $27.9M | 8,068,058 | 1.4% |
| Lenz Therapeutics Inc(LENZ) | COM | 52635N103 | $26.3M | 897,616 | 1.3% |
| Cytomx Therapeutics Inc(CTMX) | COM | 23284F105 | $25.1M | 11,065,662 | 1.3% |
| Mettler-Toledo International(MTD) | COM | 592688105 | $22.9M | 19,500 | 1.2% |
| Boeing Co(BA) | COM | 097023105 | $22.1M | 105,662 | 1.1% |
| ANI Pharmaceuticals Inc(ANIP) | COM | 00182C103 | $20.7M | 317,500 | 1.0% |
| Nvidia Corporation(NVDA) | COM | 67066G104 | $20.6M | 130,509 | 1.0% |
| Jazz Pharmaceuticals PLC(JAZZ) | SHS USD | G50871105 | $20.2M | 190,000 | 1.0% |
| Insmed Inc(INSM) | COM PAR $.01 | 457669307 | $20.1M | 200,000 | 1.0% |
| Dynavax Technologies Corp(DVAX) | COM NEW | 268158201 | $19.3M | 1,949,500 | 1.0% |
| Meta Platforms Inc(META) | CL A | 30303M102 | $19.2M | 26,008 | 1.0% |
| Adma Biologics Inc(ADMA) | COM | 000899104 | $19.1M | 1,050,000 | 1.0% |
| Keros Therapeutics Inc(KROS) | COM | 492327101 | $18.9M | 1,418,984 | 1.0% |
| Neurocrine Biosciences Inc(NBIX) | COM | 64125C109 | $18.9M | 150,000 | 1.0% |
| Avadel Pharmaceuticals PLC | COM SHS | G29687103 | $18.6M | 2,097,500 | 0.9% |
| Atea Pharmaceuticals Inc(AVIR) | COM | 04683R106 | $17.6M | 4,889,200 | 0.9% |
| GSK PLC(GSK) | SPONSORED ADR | 37733W204 | $15.4M | 400,000 | 0.8% |
| Cybin Inc(HELP) | COM NEW | 23256X407 | $15.4M | 1,830,097 | 0.8% |
| Liquidia Corporation(LQDA) | COM NEW | 53635D202 | $14.3M | 1,143,759 | 0.7% |
| Zymeworks Inc(ZYME) | COM | 98985Y108 | $13.8M | 1,100,000 | 0.7% |
| Urogen Pharma LTD(URGN) | COM | M96088105 | $13.7M | 1,000,000 | 0.7% |
| Journey MED Corp(DERM) | COM | 48115J109 | $13.3M | 1,854,596 | 0.7% |
| Cargo Therapeutics Inc(CRGX) | COM | 14179K101 | $12.6M | 3,059,630 | 0.6% |
| Teladoc Health Inc(TDOC) | COM | 87918A105 | $12.2M | 1,400,000 | 0.6% |
| Nkarta Inc(NKTX) | COM | 65487U108 | $11.7M | 7,055,576 | 0.6% |
| Elanco Animal Health Inc(ELAN) | COM | 28414H103 | $11.4M | 800,100 | 0.6% |
| Vanda Pharmaceuticals Inc(VNDA) | COM | 921659108 | $11.1M | 2,353,307 | 0.6% |
| Altimmune Inc(ALT) | COM NEW | 02155H200 | $10.6M | 2,750,000 | 0.5% |
| Astrazeneca PLC(AZN) | SPONSORED ADR | 046353108 | $10.5M | 150,000 | 0.5% |
| Travere Therapeutics Inc(TVTX) | COM | 89422G107 | $10.4M | 700,000 | 0.5% |